Even in the era of this study, the Cath and intervention rate for NSTEMI at my Center was much higher than was seen in this study, and the catheter thrombus issue was a significant concern among the intervention group.
Of course, how an early invasive strategy for NSTEMI became the prevalent norm is a different matter. I wonder if you will be reviewing tactics TIMi 18, or if I’ve missed that already.
These are good points! Yes, we will be reviewing TACTICS TIMI 18 in the intervention trials. Right now, we are still going through the medication trials.
Even in the era of this study, the Cath and intervention rate for NSTEMI at my Center was much higher than was seen in this study, and the catheter thrombus issue was a significant concern among the intervention group.
Of course, how an early invasive strategy for NSTEMI became the prevalent norm is a different matter. I wonder if you will be reviewing tactics TIMi 18, or if I’ve missed that already.
These are good points! Yes, we will be reviewing TACTICS TIMI 18 in the intervention trials. Right now, we are still going through the medication trials.